Market Access Strategy for Medical Devices in Europe
Strategic recommendations on the topic of market access pathways for medical devices and IVD tests
Recent news and posts
Intra-DRG list updated in France
In France, certain medical devices are financed within the DRG tariff but require an explicit review of clinical evidence by the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS) to ensure that they are safe and effective. This mechanism is called “intra-DRG (intra-GHS) coverage”. The mechanism applies to invasive devices. Only devices listed in the intra-DRG list can be purchased by hospitals.
In August 2025, the updated version of the intra-DRG list was published.
One new device was registered under Title I, "Cardiac and vascular implants", Chapter 6 "Thrombectomy Devices", Section 1 "Balloon guide catheters" of the List:
- Balloon guide catheter BOBBY by MicroVention for managing acute ischemic stroke using a mechanical thrombectomy device (stent retriever or thromboaspiration) in the selected indications.
Another change concerned the renewal of the registration for one device.
See more details in French here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.